Status
Conditions
Treatments
About
The purpose of this pilot study is to evaluate the effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Sleep Quality, Mood and Memory.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Subject satisfies any one or more of the contraindications for TMS Therapy per current treatment guidelines as determined by the PI.
History of head trauma associated with loss of consciousness or diagnosed as concussion.
History of fainting, syncope, hearing problems or ringing in the ears (tinnitus)
Has any metallic implant(s) in or near the head (e.g., pacemaker, defibrillator, neurostimulator, etc.) including any splinters, fragments, clips, etc.
Has an implanted stimulator device (including device leads) in or near the head.
(e.g. deep brain stimulator, cochlear implant, vagus nerve stimulator.)
Has medication infusion device.
Subjects with any prior TMS or MRI complications which, in the opinion of the investigator, might interfere with safety, study participation, or which might confound data interpretation,
Current diagnosis of a Substance Use Disorder (Abuse or Dependence, as defined by DSM-IV-TR), with the exception of nicotine dependence.
Current diagnosis or known history of neurologic or neuropsychiatric disease (e.g., epilepsy, convulsion, seizure)
Has a clinically significant abnormality on the screening examination that might affect safety, study participation, or confound interpretation of study results.
Participation in any clinical trial with an investigational drug or device within the past month or concurrent with study participation.
Primary purpose
Allocation
Interventional model
Masking
30 participants in 1 patient group
Loading...
Central trial contact
Michele Duley; Scott Gerrish
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal